Timing of cardiovascular magnetic resonance in clinical trials evaluating cardioprotective therapies to reduce infarct size

Affiliations

• ¹ College of Medicine and Public Health, Flinders University, Adelaide, Australia; Department of Cardiovascular Medicine, Flinders Medical Centre, Adelaide, Australia; South Australian Health and Medical Research Institute, Adelaide, Australia. Electronic address: joseph.selvanayagam@flinders.edu.au.
• ² College of Medicine and Public Health, Flinders University, Adelaide, Australia; Department of Cardiovascular Medicine, Flinders Medical Centre, Adelaide, Australia; South Australian Health and Medical Research Institute, Adelaide, Australia.
• ³ Department of Cardiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK; Caristo Diagnostics Ltd, Whichford House, Parkway Court, John Smith Dr, Oxford, UK.
• ⁴ National Institute for Health (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom; Division of Cardiovascular Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford John Radcliffe Hospital, Oxford, United Kingdom.